Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the University of Virginia School of Medicine and Cedars-Sinai suggests.
Superbugs, antibiotic resistance get renewed scrutiny in Congress
Melanie Lawrence doesn’t think she’ll live long enough to see her son graduate college. Lawrence, a patient with cystic fibrosis from Massachusetts, has been on